MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Retinal layer thinning in de novo Parkinson’s disease

A. Chrysou, N. Jansonius, T. van Laar (Groningen, Netherlands)

Meeting: 2019 International Congress

Abstract Number: 1874

Keywords: Neurophysiology

Session Information

Date: Wednesday, September 25, 2019

Session Title: Neuroimaging

Session Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Objective: To identify and substantiate the occurrence, extent and location of retinal degeneration in de novo Parkinson’s disease patients (PD) compared to primary open angle glaucoma patients (POAG) and healthy controls (HC).

Background: PD patients experience visual symptoms and retinal degeneration. Studies using spectral-domain optical coherence tomography (SD-OCT) have shown retinal thinning in PD, resembling the glaucoma pattern. This study investigated the retinal thinning in de novo Ldopa-naive PD patients, to analyse if the profile of retinal thinning could serve as a biomarker for PD.

Method: SD-OCT data were collected in de novo Ldopa-naive PD patients at the University Medical Center Groningen. A 5×5 mm OD macular scan was made. These scans were compared to age-matched POAG patients and HC’s. Good quality scans (≥4); segmented by Iowa Reference Algorithms [1], were divided by ETDRS 9-sector grid, and were meta-analyzed by cell-layers (Cohen’s d; 95% CI).

Results: In total 70 PD, 80 POAG patients and 61 HC were included. In PD versus HC, significant thinning was found in the inner plexiform layer (d=-0.50; 95% CI: -0.67, -0.32), outer nuclear layer (-0.18; -0.34, -0.02) and the retinal pigment epithelium (-0.12; -0.15, -0.08). Significant thickening was found in the inner nuclear layer (0.24; 0.15, 0.34), and the outer segment (0.31; 0.26, 0.35). In PD compared to glaucoma, the outer segment was thinner in PD (-0.46; -0.21, 0.10), the retinal nerve fiber layer and outer nuclear layer were not significantly different, and the ganglion cell layer (0.96; 1.96, 0.07), the inner plexiform layer (1.03; 1.60, 0.09), inner nuclear layer (0.05; 0.34, 0.10), outer plexiform layer (0.36; 0.73, 0.10), inner/outer segment junction (0.23; 0.71, 0.09), outer segment (-0.46; -0.21, 0.10) and retinal pigment epithelium (0.15; 0.23, 0.11) were significantly thinner in glaucoma.

Conclusion: De novo Ldopa-naive PD patients already show significant thinning of the inner retinal layers compared to HC. Thinning of the inner plexiform layer indicates pathology of the amacrine cells, which includes dopaminergic neurons. POAG compared to PD however showed a more severe retinal degeneration, whereas the inner plexiform layer was more severely affected in PD. Therefore, severity of amacrine cell loss possibly may serve as a potential biomarker for diagnosing PD.

References: [1] M.D. Abramoff, M.K. Garvin, M. Sonka, Retinal Imaging and Image Analysis, IEEE Rev. Biomed. Eng. 3 (2010) 169–208. doi:10.1109/RBME.2010.2084567.

To cite this abstract in AMA style:

A. Chrysou, N. Jansonius, T. van Laar. Retinal layer thinning in de novo Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/retinal-layer-thinning-in-de-novo-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/retinal-layer-thinning-in-de-novo-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley